SUPERBRANCHE
Created in 2019
Trend leader (A+)
Existing signals make this entity one of the most dynamic startupsSocial networks
1,481Activities
Technologies
Entity types
Location
Institut de Science et d'Ingénierie Supramoléculaires, 8 All. Gaspard Monge 2, 67000 Strasbourg, France
Strasbourg
France
Employees
Scale: 2-10
Estimated: 10
Engaged catalyst
17
0 0Added in Motherbase
1 year, 8 months ago
Value proposition
Nanomaterials as Nanomedicines: let's play collective!
SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer
We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand.
We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size.
Our modular technology platform presents both therapeutic and diagnosis applications. It consists in a magnetic nanoparticle coated by a tailor made branched architecture.
Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously,
thus helping to the early detection and treatment of metastases.
The main advantage of the SUPERBRANCHE technology stem from
our specific processes and synthesis know-how which are at the heart of our innovations.
Superbranche is a Biotechnology company characterized by two main activities:
- the sale of dendrimers and nanoparticles as research products to any laboratory in the field of nanomedicine
- conducting development partnerships to bring to the clinics targeted diagnostic and image-guided therapy nanomaterials based on its proprietary technology.
Nanoparticles, Dendrimers, Theranostics, iv injectable nanomaterials, and RUO products for nanomedicineOriginal language
Nanomaterials as Nanomedicine: let's play collective!
SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer
We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand.
We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size.
Our modular technology platform presents both therapeutic and diagnosis applications. It consists in a magnetic nanoparticle coated by a tailor made branched architecture.
Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously,
thus helping to the early detection and treatment of metastases.
The main advantage of the SUPERBRANCHE technology stem from
our specific processes and synthesis know-how which are at the heart of our innovations.
Superbranche is a Biotechnology company characterized by two main activities:
- the sale of dendrimers and nanoparticles as research products to any laboratory in the field of nanomedicine
- conducting development partnerships to bring to the clinics targeted diagnostic and image-guided therapy nanomaterials based on its proprietary technology.
SuperBranche | Let's Play Collective ! Biotech Strasbourg
Superbranche, Des Nanoparticules qui révolutionnent le diagnostic / traitement des tumeurs cancéreuses et le suivi des thérapies cellulaires
https://www.superbranche.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Scal'E-Nov Startup accelerator & VC | Scal'E-Nov Startup accelerator & VC | Other | ||
 Quest for health Startup accelerator & VC | Quest for health Startup accelerator & VC | Other 9 Feb 2025 | | |
 Quest for change Startup accelerator & VC | Quest for change Startup accelerator & VC | Other 7 Feb 2025 | | |
 Avolta Finance, Investment Banking | Avolta Finance, Investment Banking | Other 31 Jan 2025 | | |
 | Gouvernement | Other 23 Jun 2024 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 7 Feb 2025 | | |
 ADEME National and local authorities, Environmental Services | ADEME National and local authorities, Environmental Services | Other 23 Jun 2024 | | |
 Région Grand Est National and local authorities, Government Administration | Région Grand Est National and local authorities, Government Administration | Other 7 Feb 2025 | | |
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 21 Feb 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 7 Feb 2025 | | |